求文献，谢谢# Biology - 生物学
s*i
1 楼
在国内读了两年博士然后退学来的美国。请问简历中这两年应该怎么写比较好？写
doctoral candidate，还是只写所在学校院系，忽略身份？第二个方案的话会不会被误
解成粗心大意忘记写所得学位？谢谢。
doctoral candidate，还是只写所在学校院系，忽略身份？第二个方案的话会不会被误
解成粗心大意忘记写所得学位？谢谢。
g*d
2 楼
I ask for paper, due to unavailability of downloading in our hospital.
J Heart Lung Transplant. 2016 May 6. pii: S1053-2498(16)30110-3. doi: 10.
1016/j.healun.2016.04.007. [Epub ahead of print]
The effect of timing and graft dysfunction on survival and cardiac allograft
vasculopathy in antibody-mediated rejection.
Clerkin KJ1, Restaino SW1, Zorn E2, Vasilescu ER3, Marboe CC3, Mancini DM4.
Author information
Abstract
BACKGROUND:
Antibody-mediated rejection (AMR) has been associated with increased death
and cardiac allograft vasculopathy (CAV). Early studies suggested that late
AMR was rarely associated with graft dysfunction, whereas recent reports
have demonstrated an association with increased mortality. We investigated
the timing of AMR and its association with graft dysfunction, death, and CAV.
METHODS:
This retrospective cohort study identified all adult orthotopic heart
transplant (OHT) recipients (N = 689) at Columbia University Medical Center
from 2004 to 2013. There were 68 primary cases of AMR, which were stratified
by early (< 1 year post-OHT) or late (> 1 year post-OHT) AMR. Kaplan-Meier
survival analysis and modeling was performed with multivariable logistic
regression and Cox proportional hazards regression.
RESULTS:
From January 1, 2004, through October 1, 2015, early AMR (median 23 days
post-OHT) occurred in 43 patients and late AMR (median 1,084 days post-OHT)
occurred in 25. Graft dysfunction was less common with early compared with
late AMR (25.6% vs 56%, p = 0.01). Patients with late AMR had decreased post
-AMR survival compared with early AMR (1 year: 80% vs 93%, 5 years: 51% vs
73%, p < 0.05). When stratified by graft dysfunction, only those with late
AMR and graft dysfunction had worse survival (30 days: 79%, 1 year: 64%, 5
years: 36%; p < 0.006). The association remained irrespective of age, sex,
donor-specific antibodies, left ventricular assist device use, reason for
OHT, and recovery of graft function. Similarly, those with late AMR and
graft dysfunction had accelerated development of de novo CAV (50% at 1 year;
hazard ratio, 5.42; p = 0.009), whereas all other groups were all similar
to the general transplant population.
CONCLUSIONS:
Late AMR is frequently associated with graft dysfunction. When graft
dysfunction is present in late AMR, there is an early and sustained
increased risk of death and rapid development of de novo CAV despite
aggressive treatment.
my Email: [email protected]/* */
Thank you very much.
J Heart Lung Transplant. 2016 May 6. pii: S1053-2498(16)30110-3. doi: 10.
1016/j.healun.2016.04.007. [Epub ahead of print]
The effect of timing and graft dysfunction on survival and cardiac allograft
vasculopathy in antibody-mediated rejection.
Clerkin KJ1, Restaino SW1, Zorn E2, Vasilescu ER3, Marboe CC3, Mancini DM4.
Author information
Abstract
BACKGROUND:
Antibody-mediated rejection (AMR) has been associated with increased death
and cardiac allograft vasculopathy (CAV). Early studies suggested that late
AMR was rarely associated with graft dysfunction, whereas recent reports
have demonstrated an association with increased mortality. We investigated
the timing of AMR and its association with graft dysfunction, death, and CAV.
METHODS:
This retrospective cohort study identified all adult orthotopic heart
transplant (OHT) recipients (N = 689) at Columbia University Medical Center
from 2004 to 2013. There were 68 primary cases of AMR, which were stratified
by early (< 1 year post-OHT) or late (> 1 year post-OHT) AMR. Kaplan-Meier
survival analysis and modeling was performed with multivariable logistic
regression and Cox proportional hazards regression.
RESULTS:
From January 1, 2004, through October 1, 2015, early AMR (median 23 days
post-OHT) occurred in 43 patients and late AMR (median 1,084 days post-OHT)
occurred in 25. Graft dysfunction was less common with early compared with
late AMR (25.6% vs 56%, p = 0.01). Patients with late AMR had decreased post
-AMR survival compared with early AMR (1 year: 80% vs 93%, 5 years: 51% vs
73%, p < 0.05). When stratified by graft dysfunction, only those with late
AMR and graft dysfunction had worse survival (30 days: 79%, 1 year: 64%, 5
years: 36%; p < 0.006). The association remained irrespective of age, sex,
donor-specific antibodies, left ventricular assist device use, reason for
OHT, and recovery of graft function. Similarly, those with late AMR and
graft dysfunction had accelerated development of de novo CAV (50% at 1 year;
hazard ratio, 5.42; p = 0.009), whereas all other groups were all similar
to the general transplant population.
CONCLUSIONS:
Late AMR is frequently associated with graft dysfunction. When graft
dysfunction is present in late AMR, there is an early and sustained
increased risk of death and rapid development of de novo CAV despite
aggressive treatment.
my Email: [email protected]/* */
Thank you very much.
d*u
3 楼
research assistant for 2 yrs
【在 s******i 的大作中提到】
: 在国内读了两年博士然后退学来的美国。请问简历中这两年应该怎么写比较好？写
: doctoral candidate，还是只写所在学校院系，忽略身份？第二个方案的话会不会被误
: 解成粗心大意忘记写所得学位？谢谢。
【在 s******i 的大作中提到】
: 在国内读了两年博士然后退学来的美国。请问简历中这两年应该怎么写比较好？写
: doctoral candidate，还是只写所在学校院系，忽略身份？第二个方案的话会不会被误
: 解成粗心大意忘记写所得学位？谢谢。
相关阅读
一个经常招人的PI以前的海龟是不是基本上都是小偷？ITC帮忙下个文献（多谢）分享一点转行的经验吧 (转载)LIBSHUFF软件使用求推荐 cloning plasmid姜波刚出来，Hua Jun Zhao又进去 (转载)要质粒的奇怪事，请教做promoter的大牛哪里找cancer research lab的occupational safety资料？谁投过Nature Biotechnology?MIT的synthetic biology系怎么样》？Oncogene 封 ZhChunxian 在 Biology 版Why lenti can package large pro-virus DNA审稿机会 Cancer targeted therapy (转载)宁与黑幕三，不予家奴 (转载)Please help with a paper !paper help!paper help有人想接手Bioresearch俱乐部吗？